Hypertrophy and fibrosis in the cardiomyopathy of uremia--beyond coronary heart disease.
Cardiac disease is the leading cause of death in uremic patients. In contrast to previous opinion, coronary events account for a relatively small proportion of cardiac deaths, the most common causes being sudden death and heart failure. Against this background the current text will discuss noncoronary cardiac pathology, specifically the pathogenesis and the morphological findings caused by (pathological) cardiac hypertrophy, cardiac interstitial fibrosis and microvascular disease.
Gross
Marie-Luise
ML
Department of Pathology, University of Heidelberg, Heidelberg, Germany. marie-luise_gross@med.uni-heidelberg.de
Ritz
Eberhard
E
D000818:Animals; D002312:Cardiomyopathy, Hypertrophic / Q000453:epidemiology / Q000209:etiology*; D003327:Coronary Disease / Q000453:epidemiology / Q000209:etiology*; D016757:Death, Sudden, Cardiac / Q000453:epidemiology; D018450:Disease Progression; D005355:Fibrosis / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D015994:Incidence; D009206:Myocardium / Q000473:pathology*; D015996:Survival Rate; D014481:United States / Q000453:epidemiology; D014511:Uremia / Q000150:complications*